Rare Disease Day 2024 - Call for greater awareness of X-link

/PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS)...

Related Keywords

United States , Spain , Barcelona , Comunidad Autonoma De Cataluna , Belgium , Germany , Paris , France General , France , Belgian , America , Karen Harrison , Thomas Dierks , Laboratorios Lesvi , Fanny Mochel , Marc Martinell , Neuraxpharm Pharmaceuticals , Youtube , Reference Center , Neuraxpharm Group , Linkedin , Leukodystrophy Charity , Roche Venture Fund , Prnewswire Neuraxpharm Group , Minoryx Therapeutics , Rare Disease Day , Professor Fanny Mochel , Support Services Manager , Professor Mochel , Chief Executive Officer , European Medicines Agency , Medicinal Products , Human Use , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cell Transplant , Fast Track , Rare Pediatric Disease , Latin America , Columbus Venture Partners , Caixa Capital Risc , Ysios Capital , Kurma Partners , Chiesi Ventures , Idinvest Partners ,